Wells Fargo’s Strata Critical Medical, Inc. Class A Common Stock SRTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $261K | Buy |
64,800
+29,538
| +84% | +$119K | ﹤0.01% | 4225 |
|
|
2025
Q1 | $96.3K | Buy |
35,262
+1,204
| +4% | +$3.29K | ﹤0.01% | 4667 |
|
|
2024
Q4 | $145K | Buy |
34,058
+7,418
| +28% | +$31.5K | ﹤0.01% | 4497 |
|
|
2024
Q3 | $78.3K | Sell |
26,640
-7,480
| -22% | -$22K | ﹤0.01% | 4757 |
|
|
2024
Q2 | $119K | Buy |
34,120
+10,945
| +47% | +$38.1K | ﹤0.01% | 4474 |
|
|
2024
Q1 | $66K | Buy |
23,175
+2,676
| +13% | +$7.63K | ﹤0.01% | 4767 |
|
|
2023
Q4 | $72.4K | Buy |
20,499
+3,697
| +22% | +$13.1K | ﹤0.01% | 4688 |
|
|
2023
Q3 | $43.5K | Sell |
16,802
-11,779
| -41% | -$30.5K | ﹤0.01% | 4897 |
|
|
2023
Q2 | $113K | Buy |
28,581
+13,733
| +92% | +$54.1K | ﹤0.01% | 4698 |
|
|
2023
Q1 | $50.2K | Buy |
14,848
+9,195
| +163% | +$31.1K | ﹤0.01% | 4868 |
|
|
2022
Q4 | $20.2K | Sell |
5,653
-1,833
| -24% | -$6.56K | ﹤0.01% | 4936 |
|
|
2022
Q3 | $30K | Sell |
7,486
-20,379
| -73% | -$81.7K | ﹤0.01% | 4872 |
|
|
2022
Q2 | $125K | Buy |
27,865
+19,575
| +236% | +$87.8K | ﹤0.01% | 4263 |
|
|
2022
Q1 | $70K | Sell |
8,290
-8,899
| -52% | -$75.1K | ﹤0.01% | 5166 |
|
|
2021
Q4 | $151K | Buy |
17,189
+5,332
| +45% | +$46.8K | ﹤0.01% | 5042 |
|
|
2021
Q3 | $123K | Sell |
11,857
-76,278
| -87% | -$791K | ﹤0.01% | 5006 |
|
|
2021
Q2 | $925K | Sell |
88,135
-55,833
| -39% | -$586K | ﹤0.01% | 4028 |
|
|
2021
Q1 | $1.48M | Buy |
143,968
+137,828
| +2,245% | +$1.42M | ﹤0.01% | 3719 |
|
|
2020
Q4 | $68K | Buy |
+6,140
| New | +$68K | ﹤0.01% | 5304 |
|